Business
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
IRVINE, Calif., February 26, 2026--At the close of Heart Month, Edwards Lifesciences (NYSE: EW) underscored its leadership in structural heart innovation, advancing care through deep expertise and strong partnerships so people with structural heart disease can live longer, healthier lives. As part of this commitment, Edwards announced the impact and renewed vision for Every Heartbeat Matters, its signature global health initiative, to help 2 million more patients facing barriers worldwide access
About this update from Edwards Lifesciences Corporation
[{"type":"text","content":"IRVINE, Calif., February 26, 2026--(BUSINESS WIRE)--At the close of Heart Month, Edwards Lifesciences (NYSE: EW) underscored its leadership in structural heart innovation, advancing care through deep expertise and strong partnerships so people with structural heart disease can live longer, healthier lives. As part of this commitment, Edwards announced the impact and renewed vision for Every Heartbeat Matters, its signature global health initiative, to help 2 million more patients facing barriers worldwide access lifesaving structural heart treatment by the end of 2030.","length":575,"tagName":"p"},{"type":"text","content":""For nearly 70 years, Edwards has led with a strong focus on improving the lives of patients with structural heart disease," said Bernard Zovighian, Edwards’ CEO. "It starts with breakthrough innovation, layered with world class clinical expertise, sustained commitment and strong partnerships across the global healthcare ecosystem. Every advancement we make impacts a patient, a family and a community. Our purpose is to advance science and expand access so more people can benefit."","length":505,"tagName":"p"},{"type":"text","content":"This commitment extends through the Edwards Lifesciences Foundation and Every Heartbeat Matters, which increases access to diagnosis and treatment for underserved structural heart patients, particularly those in low- and middle-income countries and regions where care is limited and barriers may be substantial. Since 2014, Every Heartbeat Matters and its charitable partners have impacted more than 4 million underserved structural heart patients globally.","length":457,"tagName":"p"},{"type":"text","content":""Improving the lives of patients with structural heart disease is core to who we are," Zovighian said. "Through Every Heartbeat Matters and our global partners, we are breaking down financial, systemic and geographic barriers so that underserved patients can get access to care that can change the trajectory of their lives. We innovate with purpose, we are powered by science and we remain centered on patients."","length":433,"tagName":"p"},{"type":"text","content":"More information on the Edwards Lifesciences Foundation and Every Heartbeat Matters is available at www.edwards.com/corporategiving or www.everyheartbeatmatters.org.","length":...